Astrana Health, Inc. (NASDAQ:ASTH) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have received an average rating of “Moderate Buy” from the nine brokerages that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $53.29.

ASTH has been the subject of a number of recent analyst reports. Truist Financial reduced their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research note on Tuesday, March 18th. Robert W. Baird reduced their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Stifel Nicolaus cut their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Barclays began coverage on Astrana Health in a research note on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price target for the company. Finally, Bank of America cut their price target on Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in Astrana Health by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company’s stock worth $151,918,000 after purchasing an additional 213,033 shares during the period. Dimensional Fund Advisors LP boosted its stake in Astrana Health by 10.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company’s stock worth $32,968,000 after purchasing an additional 101,192 shares during the period. 325 Capital LLC raised its holdings in shares of Astrana Health by 30.3% in the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company’s stock valued at $27,964,000 after acquiring an additional 206,009 shares in the last quarter. SteelPeak Wealth LLC raised its holdings in shares of Astrana Health by 4.8% in the 1st quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company’s stock valued at $17,619,000 after acquiring an additional 26,192 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Astrana Health by 6.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock valued at $15,490,000 after acquiring an additional 28,200 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Trading Down 2.3%

NASDAQ ASTH opened at $25.75 on Tuesday. The firm has a market capitalization of $1.44 billion, a P/E ratio of 19.81, a PEG ratio of 1.37 and a beta of 0.85. The business has a fifty day simple moving average of $28.71 and a 200 day simple moving average of $32.32. Astrana Health has a 12 month low of $23.12 and a 12 month high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.09). The business had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm’s revenue for the quarter was up 53.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.31 EPS. On average, analysts predict that Astrana Health will post 1.15 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.